Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch
Executive Summary
Jim O'Neill, a Silicon Valley investment manager, would be an unusual choice to head US FDA, not just because he isn’t a physician, but because he’s favored substantially reducing FDA's role in assessing product effectiveness. While some experts are highly skeptical about O'Neill, who worked at HHS in the Bush administration, others suggest he could champion much-needed change at the agency.
You may also be interested in...
US FDA Commissioner A 'Star' At Davos: Hopefully Not A Bad Omen
President Trump singles out Scott Gottlieb during dinner meeting at World Economic Forum. Does that make anyone else nervous?
US FDA’s Bipartisan Support May Offer Shelter From Political Winds, Former Chief Says
In the wake of 21st Century Cures legislation, next commissioner will have strong support across party lines to undertake smarter regulation aimed at improving the efficiency of the drug development process, former FDA head McClellan says.
US FDA Commissioner Search: Pharma’s Preferred Candidate Is Gottlieb
Analyst poll of 53 drug companies indicates broad support for Scott Gottlieb compared to three other known candidates for FDA Commissioner.